Mibefradil, a T-type Ca2+ channel blocker also blocks Orai channels by action at the extracellular surface.
Pengyun LiHussein N RubaiyGui-Lan ChenThomas HallettNawel ZaibiBo ZengRahul SaurabhShang-Zhong XuPublished in: British journal of pharmacology (2019)
Mibefradil is a potent cell surface blocker of Orai channels, demonstrating a new pharmacological action of this compound in regulating cell growth and death, which could be relevant to its anti-cancer activity.